Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 01, 2020

SELL
$258.66 - $342.55 $12,933 - $17,127
-50 Closed
0 $0
Q1 2020

Apr 01, 2020

BUY
$268.85 - $341.04 $13,442 - $17,052
50 New
50 $15,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $26.4B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Cox Capital Mgt LLC Portfolio

Follow Cox Capital Mgt LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cox Capital Mgt LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cox Capital Mgt LLC with notifications on news.